Get the latest Science News and Discoveries

New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound


The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much

None

Get the Android app

Or read this on Scientific American

Read more on:

Photo of Wegovy

Wegovy

Photo of loss drugs

loss drugs

Photo of Zepbound

Zepbound

Related news:

News photo

The overlooked nutrition risk of Ozempic and Wegovy

News photo

Experts Sound Alarm Over Nutritional Gaps in People Taking Ozempic and Wegovy

News photo

How Ozempic and Wegovy are quietly cutting America’s food bills